BioCardia, Inc. (BCDA) stock
BCDANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$0.92−0.01 (-0.91%)
Close on Nov 11, 2026Market cap $13.95MP/E –Yield –
BioCardia ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
BioCardia's ebitda for the twelve months ending Jun 30, 2026 was -$7.38M. For fiscal 2025 it was -$8.25M. The highest annual figure on record is $384.00K in fiscal 2010.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$8.25M | – |
| FY2024 | Dec 31, 2024 | -$7.93M | – |
| FY2023 | Dec 31, 2023 | -$11.56M | – |
| FY2022 | Dec 31, 2022 | -$11.82M | – |
| FY2021 | Dec 31, 2021 | -$12.57M | – |
| FY2020 | Dec 31, 2020 | -$15.46M | – |
| FY2019 | Dec 31, 2019 | -$14.10M | – |
| FY2018 | Dec 31, 2018 | -$14.01M | – |
| FY2017 | Dec 31, 2017 | -$12.33M | – |
| FY2016 | Dec 31, 2016 | -$7.57M | – |
| FY2015 | Dec 31, 2015 | -$5.36M | – |
| FY2011 | Dec 31, 2011 | -$618.00K | -260.9% |
| FY2010 | Dec 31, 2010 | $384.00K | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$1.62M | – |
| Q1 FY2026 | Mar 31, 2026 | -$2.26M | – |
| Q4 FY2025 | Dec 31, 2025 | -$2.01M | – |
| Q3 FY2025 | Sep 30, 2025 | -$1.48M | – |
| Q2 FY2025 | Jun 30, 2025 | -$2.05M | – |
| Q1 FY2025 | Mar 31, 2025 | -$2.71M | – |
| Q4 FY2024 | Dec 31, 2024 | -$2.31M | – |
| Q3 FY2024 | Sep 30, 2024 | -$1.74M | – |
| Q2 FY2024 | Jun 30, 2024 | -$1.63M | – |
| Q1 FY2024 | Mar 31, 2024 | -$2.26M | – |
| Q4 FY2023 | Dec 31, 2023 | -$2.06M | – |
| Q3 FY2023 | Sep 30, 2023 | -$2.58M | – |
| Q2 FY2023 | Jun 30, 2023 | -$3.43M | – |
| Q1 FY2023 | Mar 31, 2023 | -$3.49M | – |
| Q4 FY2022 | Dec 31, 2022 | -$3.00M | – |
| Q3 FY2022 | Sep 30, 2022 | -$3.03M | – |
| Q2 FY2022 | Jun 30, 2022 | -$2.48M | – |
| Q1 FY2022 | Mar 31, 2022 | -$3.31M | – |
| Q4 FY2021 | Dec 31, 2021 | -$3.45M | – |
| Q3 FY2021 | Sep 30, 2021 | -$2.69M | – |
| Q2 FY2021 | Jun 30, 2021 | -$3.47M | – |
| Q1 FY2021 | Mar 31, 2021 | -$2.96M | – |
| Q4 FY2020 | Dec 31, 2020 | -$3.48M | – |
| Q3 FY2020 | Sep 30, 2020 | -$3.83M | – |
| Q2 FY2020 | Jun 30, 2020 | -$3.56M | – |
| Q1 FY2020 | Mar 31, 2020 | -$4.59M | – |
| Q4 FY2019 | Dec 31, 2019 | -$3.50M | – |
| Q3 FY2019 | Sep 30, 2019 | -$3.20M | – |
| Q2 FY2019 | Jun 30, 2019 | -$3.74M | – |
| Q1 FY2019 | Mar 31, 2019 | -$3.66M | – |
| Q4 FY2018 | Dec 31, 2018 | -$3.64M | – |
| Q3 FY2018 | Sep 30, 2018 | -$3.55M | – |
| Q2 FY2018 | Jun 30, 2018 | -$3.23M | – |
| Q1 FY2018 | Mar 31, 2018 | -$3.60M | – |
| Q4 FY2017 | Dec 31, 2017 | -$3.50M | – |
| Q3 FY2017 | Sep 30, 2017 | -$3.02M | – |
| Q2 FY2017 | Jun 30, 2017 | -$2.95M | – |
| Q1 FY2017 | Mar 31, 2017 | -$2.86M | – |
| Q4 FY2016 | Dec 31, 2016 | -$3.46M | – |
| Q3 FY2016 | Sep 30, 2016 | -$1.67M | – |
See a number that looks wrong?